Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Kseniya Kobets MD MHS, one of the co-authors of “Disparities in Hidradenitis Suppurativa Clinical Trials: An Updated Review…
Medscape featured a December Journal of Drugs in Dermatology study on the link between isotretinoin and inflammatory bowel disease (IBD). The study, “Isotretinoin Does Not Increase the Risk of Inflammatory…
Analysis of the top 50 Instagram posts finds physician content more reliable but represents only a quarter of popular posts In one of our January JDD articles, it focuses on…
From the Vault: PLLA‑SCA injections deliver durable cheek wrinkle improvement and high patient satisfaction We are highlighting one of our popular articles from the vault: a January 2024 read that…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Title: Novel Treatments and Clinical Insights Shaping Dermatology As we head into the new year, it’s important to highlight some of the pieces that helped clarify the role of novel…
See JDD author Dr. Andrew Blauvelt bring cutting‑edge psoriasis science to life in GWU’s Dermatology Translational Science Lecture Series, and learn about his new Nature study on high‑induction risankizumab dosing.…
Thiamidol shows rapid, sustained benefit for facial hyperpigmentation We’re highlighting a December 2025 article that we’re sure you’ll want to dive into! A 90‑patient randomized study found that thiamidol formulations…
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability From the Editor-in-Chief Dear Readers, As we look back on 2025, one…
Minocycline ER spares the microbiome: A December JDD highlight In the December issue of JDD we wanted to highlight a randomized, double‑blind, placebo‑controlled microbiome study of DFD‑29 (minocycline hydrochloride extended‑release…